Hotel Dieu De France Hospital

This study is testing if a diabetes drug called empagliflozin can reduce harmful inflammation that occurs after a heart stent procedure. About 100 patients with stable coronary artery disease will take the drug or a placebo for three days before their scheduled stent placement. R…